| P2093 | author name string | R Zhang | |
| | E Wood | |
| | M-J Milloy | |
| | T Kerr | |
| | J Montaner | |
| | B Mann | |
| P2860 | cites work | Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients | Q57259633 |
| | Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up | Q57259766 |
| | Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use | Q57259780 |
| | Sociodemographic and psychological variables influencing adherence to antiretroviral therapy | Q59858382 |
| | HIV in the United States at the turn of the century: an epidemic in transition | Q64129272 |
| | A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team | Q71545355 |
| | Adherence to triple therapy and viral load response | Q73848665 |
| | Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review | Q22242638 |
| | Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review | Q28295247 |
| | Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare | Q33863309 |
| | Factors affecting adherence to antiretroviral therapy | Q33946925 |
| | A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team | Q34438252 |
| | Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users | Q34754918 |
| | Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users | Q35078732 |
| | Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs | Q35147189 |
| | Substance abuse and medication adherence among HIV-positive women with histories of child sexual abuse | Q35429075 |
| | Treatment of antiretroviral-drug-resistant HIV-1 infection | Q35610798 |
| | Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users | Q36065237 |
| | Clinical care of the HIV-infected drug user | Q36248580 |
| | Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis | Q37330136 |
| | An evidence-based review of treatment-related determinants of patients' nonadherence to HIV medications | Q37566637 |
| | Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients | Q38959219 |
| | Adherence to protease inhibitor therapy and outcomes in patients with HIV infection | Q39605935 |
| | Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L | Q43689007 |
| | Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use. | Q43890758 |
| | Highly active antiretroviral therapy and survival in HIV-infected injection drug users. | Q43903854 |
| | Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver | Q43909228 |
| | Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users | Q44110290 |
| | Nonadherence among HIV-infected injecting drug users: the impact of social instability | Q44299315 |
| | Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy | Q45710860 |
| | Adherence to highly active antiretroviral therapy (HAART): a meta-analysis | Q45889695 |
| | Better maintained adherence on switching from twice-daily to once-daily therapy for HIV: a 24-week randomized trial of treatment simplification using stavudine prolonged-release capsules | Q46474210 |
| | Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy | Q50114681 |
| | Ongoing drug use and outcomes from highly active antiretroviral therapy among injection drug users in a Canadian setting | Q50132074 |
| | Barriers to use of free antiretroviral therapy in injection drug users | Q50159275 |
| | Simulation study of confounder-selection strategies. | Q52884423 |
| | Self-reported antiretroviral therapy in injection drug users. | Q53352327 |
| | Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users. | Q53507690 |
| P433 | issue | 10 | |
| P921 | main subject | anti-retroviral agent | Q50430310 |
| P304 | page(s) | 596-601 | |
| P577 | publication date | 2012-05-02 | |
| P1433 | published in | HIV Medicine | Q15756376 |
| P1476 | title | Improved adherence to modern antiretroviral therapy among HIV-infected injecting drug users | |
| P478 | volume | 13 | |